Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis

被引:53
|
作者
Andersson, M. L. E.
Petersson, I. F.
Karlsson, K. E.
Jonsson, E. N.
Mansson, B.
Heinegard, D.
Saxne, T.
机构
[1] Spenshults Hosp Rheumat Dis, Halmstad, Sweden
[2] Lund Univ, Dept Rheumatol, Lund, Sweden
[3] Lund Univ, Sect Cell & Matrix Biol, Dept Expt Med Sci, Lund, Sweden
[4] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden
关键词
D O I
10.1136/ard.2005.051292
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To monitor changes in serum concentrations of cartilage oligomeric matrix protein (COMP) during a 24-h period to determine any diurnal variation, and to estimate the half life of COMP in the circulation in patients with symptomatic knee osteoarthritis and in those with rheumatoid arthritis. Methods: Serum samples were drawn every 4 h (7 samples/patient over 24 h) in 10 patients with knee osteoarthritis and 14 patients with rheumatoid arthritis. Osteoarthritis was defined radiographically and clinically (American College of Rheumatology (ACR) criteria) and rheumatoid arthritis according to the 1987 ACR criteria. Serum COMP was measured by sandwich ELISA. A statistical model for the diurnal variation in the COMP levels was developed using the computer program NONMEM. Results: No considerable changes in COMP levels were observed during the day between 08:00 and 21:00 in either group. A significant decrease in serum COMP was apparent during bed rest at night, reaching the lowest levels between 04:00 and 05:00 (p < 0.03 or better v all other time points) in patients with osteoarthritis and in those with rheumatoid arthritis. From the rate of decreasing serum COMP levels, a putative half life of COMP in the circulation was estimated to be 7.4 h. Conclusion: During normal daytime activities, serum COMP levels are constant. The decrease during the night indicates a rapid elimination of COMP once it has reached the circulation. The stable COMP levels during the day suggest that it is not necessary to further standardise the time of serum sampling in clinical practice.
引用
收藏
页码:1490 / 1494
页数:5
相关论文
共 50 条
  • [41] Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment
    Skoumal, M.
    Haberhauer, G.
    Feyertag, J.
    Kittl, E. M.
    Bauer, K.
    Dunky, A.
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (11) : 1001 - 1004
  • [42] Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment
    M. Skoumal
    G. Haberhauer
    J. Feyertag
    E. M. Kittl
    K. Bauer
    A. Dunky
    Rheumatology International, 2006, 26 : 1001 - 1004
  • [43] Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats
    Vingsbo-Lundberg, C
    Saxne, T
    Olsson, H
    Holmdahl, R
    ARTHRITIS AND RHEUMATISM, 1998, 41 (03): : 544 - 550
  • [44] Meta-analysis of serum C-reactive protein and cartilage oligomeric matrix protein levels as biomarkers for clinical knee osteoarthritis
    Zhang, Junfeng
    BMC MUSCULOSKELETAL DISORDERS, 2018, 19
  • [45] Meta-analysis of serum C-reactive protein and cartilage oligomeric matrix protein levels as biomarkers for clinical knee osteoarthritis
    Junfeng Zhang
    BMC Musculoskeletal Disorders, 19
  • [46] High specificity but low sensitivity of the cartilage oligomeric matrix protein (COMP) test in rheumatoid arthritis and osteoarthritis
    Bender, Ana Ligia
    da Silveira, Ines Guimaraes
    von Muehlen, Carlos Alberto
    Staub, Henrique Luiz
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2010, 48 (04) : 569 - 570
  • [47] Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: a systematic review and meta-analysis
    Hoch, J. M.
    Mattacola, C. G.
    McKeon, J. M. Medina
    Howard, J. S.
    Lattermann, C.
    OSTEOARTHRITIS AND CARTILAGE, 2011, 19 (12) : 1396 - 1404
  • [48] Response of Cartilage Oligomeric Matrix Protein to Monoclonal Antibody Drugs in Patients with Rheumatoid Arthritis
    Tampoia, Marilina
    Brescia, Vincenzo
    Falappone, Paola
    Zucano, Antonietta
    Scioscia, Crescenzo
    Fontana, Antonietta
    Iannone, Florenzo
    Di Serio, Francesca
    Lapadula, Giovanni
    LABMEDICINE, 2009, 40 (11): : 645 - 650
  • [49] Increased serum levels of cartilage oligomeric matrix protein precede the clinical onset of rheumatoid arthritis despite lower levels among smokers
    Turesson, Carl
    Bergstrom, Ulf
    Jacobsson, Lennart T. H.
    Berglund, Goeran
    Saxne, Tore
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S289 - S290
  • [50] Cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and its correlation with sonographic knee cartilage thickness and disease activity
    Sakthiswary, Rajalingham
    Rajalingam, Shamala
    Hussein, Heselynn
    Sridharan, Radhika
    Asrul, Abdul Wahab
    CLINICAL RHEUMATOLOGY, 2017, 36 (12) : 2683 - 2688